Lyra Therapeutics Cash Flow Statement 2019-2025 | LYRA

Fifteen years of historical annual cash flow statements for Lyra Therapeutics (LYRA).

Annual Data | Millions of US $ except per share data

Metric Name
Net Income/Loss
Total Depreciation And Amortization - Cash Flow
Other Non-Cash Items
Total Non-Cash Items
Change In Accounts Receivable
Change In Inventories
Change In Accounts Payable
Change In Assets/Liabilities
Total Change In Assets/Liabilities
Cash Flow From Operating Activities
Net Change In Property, Plant, And Equipment
Net Change In Intangible Assets
Net Acquisitions/Divestitures
Net Change In Short-term Investments
Net Change In Long-Term Investments
Net Change In Investments - Total
Investing Activities - Other
Cash Flow From Investing Activities
Net Long-Term Debt
Net Current Debt
Debt Issuance/Retirement Net - Total
Net Common Equity Issued/Repurchased
Net Total Equity Issued/Repurchased
Total Common And Preferred Stock Dividends Paid
Financial Activities - Other
Cash Flow From Financial Activities
Net Cash Flow
Stock-Based Compensation
Common Stock Dividends Paid
202420232022202120202019
$-93.44$-62.68$-55.28$-43.51$-22.13$-16.31
$-1.81$-3.22$0.58$1.00$0.10$0.03
$31.58$7.48$6.76$2.77$1.77$0.41
$29.77$4.26$7.34$3.77$1.86$0.44
$0$0$0$0$0$0
$0$0$0$0$0$0
$-1.89$0.45$-2.41$2.35$0.35$-0.21
$1.52$-6.83$2.19$10.33$-1.14$0.59
$-6.35$-4.89$4.56$13.92$-0.88$2.11
$-70.01$-63.30$-43.39$-25.82$-21.14$-13.75
$-2.34$-1.05$-0.16$-3.39$-1.78$-0.21
$0$0$0$0$0$0
$0$0$0$0$0$0
$82.64$-11.54$0$0$0$0
$0$0$-64.84$0$0$0
$82.64$-11.54$-64.84$0$0$0
$0$0$0$0$0$0
$80.31$-12.58$-65.01$-3.39$-1.78$-0.21
$0$0$0$0$0$0
$0$0$0$0$0$0
$0$0$0$0$0$0
$8.82$69.35$101$0.60$59.90$0.11
$8.82$69.35$101$0.60$90.29$0.11
$0$0$0$0$0$0
$-0.29$-3.65$-4.25$-0.25$-2.59$-0.23
$8.53$65.69$96.26$0.36$87.70$-0.12
$18.83$-10.20$-12.13$-28.85$64.79$-14.08
$6.72$5.89$5.45$2.77$1.81$0.24
$0$0$0$0$0$0